Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors - Regional Cancer Care Associates LLC

Clinical Trials

Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Bristol-Myers Squibb
Protocol Number
Bristol Myers Squibb CA020-002
Cancer Diagnosis
To Learn More Call
201-510-0910